Strategic Impact for Life-Science companies
We help life-science companies turn complex clinical, medical and commercial challenges into clear strategies and actionable plans.
With deep industry expertise across the product lifecycle, we connect strategy, evidence, people and execution to help critical initiatives move forward.
From clinical trials and Medical Affairs to product strategy and Managed Access Programmes, we help life-science leaders turn complex challenges into clear priorities, aligned action and measurable progress.
Build Medical Affairs capabilities that deliver.
We help design organisational structures, priorities, key deliverables and operating models that support effective Medical Affairs across the product lifecycle.
Turn medical strategy into an executable plan.
We develop comprehensive medical plans that connect scientific and commercial objectives, identify evidence gaps and plan evidence generation, including Real-World Evidence.
Design and operationalise MAP with a clear path to execution.
We help sponsors define programme scope and governance, establish the operating model and coordinate execution across internal functions and specialist vendors.
Improve trial recruitment, retention and data quality.
We use behavioural science and novel approaches to build stronger trial communities among KOLs, investigators and study coordinators, supporting more effective clinical trials from Phase 2b onwards.
Connect the decisions across the product lifecycle.
We align clinical, medical and commercial perspectives from Target Product Profile through go-to-market planning and beyond.
Insights
Selected case stories from our work with life science companies
From EAP complexity to an execution-ready model
A mid-sized pharmaceutical company with limited Early Access Programme experience needed to establish a clear and scalable model for rollout across selected countries.
Accelerating Recruitment in a Competitive Phase 2b Trial
Mid-sized pharma reached enrolment targets on time through InnoStrat’s Clinical Trial Effectiveness strategy and local trial community engagement.
Market Readiness for a Biotech’s product launch
We helped a biotech company align its clinical, medical, and commercial functions ahead of its first launch.
Launch Strategy in a New Therapy Area
A global pharma company was entering into an unfamiliar disease area. InnoStrat supported the client’s cross-functional team with using market insights and clarifying its value messaging. This ensured both internal clarity and improved market traction.
Making Data Speak
InnoStrat helped translate complex clinical data into clear insights, ensuring important evidence reached clinicians faster and supported better decision-making in real-world practice.
Integrating Real-World Evidence for Market Success
For a rare-disease product launch, InnoStrat implemented a cross-functional RWE program and IT framework – combining real-world and clinical data for stronger evidence and positioning.
Medical Affairs Transformation
From service providers to strategic business partners – how we coached and helped align a global medical affairs team in the middle of a broader organisational change.
From Webcast to Community
InnoStrat helped a biotech company transform a virtual scientific meeting into an ongoing digital platform for KOL engagement, scientific exchange, and enduring medical content.
What our clients say
Let’s talk about what’s next
Whether you’re launching into new markets, lifting your medical capabilities, or facing tough recruitment timelines, we’re here to help.
